Malaria Consortium is governed by a Board of Trustees, which meets quarterly and for its Annual General Meeting (AGM). A Finance and Audit subcommittee monitors the finances of the organisation, meeting at least quarterly, and makes recommendations to the Board of Trustees. The Board of Trustees takes the major strategic decisions for the organisation. Every year Trustees are invited to visit programmes in the field to ensure they are fully informed about Malaria Consortium’s activities at country level. Day-to-day operational decision-making is delegated to the Chief Executive, who, with the other members of the Global Management Group, runs the organisation. Our Board of Trustees are:
Our Patrons are:
Dr Julian Lob-Levyt (Chairman)
Dr. Julian Lob-Levyt is Senior Vice President, International with DAI, based in London. Dr Lob-Levyt leads the development of DAI's international operations to become a recognised global company within the field of International Development. As CEO of the GAVI Alliance between 2005 and 2010, Dr. Lob-Levyt led GAVI, resulting in the delivery of immunisation to over 250 million children, preventing more than five million deaths globally. Previously Dr. Lob-Levyt was Head of Human Development and Chief Health and Population Advisor at the UK's Department for International Development, Regional Health Advisor in Zimbabwe for the EC, led health systems reform in Cambodia, was First Secretary Health for Overseas Development Aid in Bangladesh and Chief Medical Officer in the Solomon Islands. In the 2011 Queen's birthday honours, he was awarded a CBE for 'Services to Global Health'.
Richard Page (Treasurer)
After working as an industrial statistician to the Malawi Government, Richard Page qualified as an accountant with Marconi and H.J.Heinz. He then lectured in business studies before returning to industry with Fisons Fertilisers. His senior positions have been with Kafue Textiles of Zambia as CFO and then as CEO; CFO at Nanyuki Textiles Mills in Kenya then as Finance Director in engineering and manufacturing companies in the UK. He is presently the Director of Finance with Oxleas NHS Foundation Trust. He is a Fellow of the Chartered Institute of Management Accountants and a magistrate.
Tim Armstrong has worked as a Chartered Accountant in the audit profession in Africa and the Middle East and with a leading international consultancy firm specialising in financing and managing major projects in the developing world. Tim has held a number of senior positions in UK financial regulation.
Professor Fred Binka
Professor Binka holds a PhD in Epidemiology from the University of Basel. He is currently Professor of Epidemiology and the Vice Chancellor of the University of Health and Allied Sciences Ho, Ghana. He previously served as Dean of the School of Public Health, University of Ghana and the Executive Director and Coordinator of the Secretariat at the INDEPTH Network. He was an Honorary Research Fellow in Epidemiology and Population Sciences at LSHTM from 1994 to 1999 and a member of Ghana’s National Malaria Advisory Committee. He has served on a number of international committees, including as Chairperson of the WHO Tropical Disease Research Task force on Research Capability Strengthening, member of the Board of Directors at the African Medical Research Foundation (AMREF) in Kenya, and was a founding member of the Mapping Malaria Risk in Africa (MARA) international network. He received the Rudolf Geigy Award for outstanding contributions to malaria control and health development in Africa in 2001 and the Ronald Ross medal from the London School of Hygiene and Tropical Medicine in 2010 for his contributions to malaria research and control.
Ian Boulton is currently the Managing Director of TropMed Pharma Consulting. He previously worked for 34 years in the pharmaceutical industry, with 19 years spent in Asia. He has experience in General Management, Sales & Marketing, Business Development, Strategic Planning, Corporate Acquisitions, and R&D. For the last 8 years with GlaxoSmithKline, he was one of the leaders of their Diseases of the Developing World Initiative. He has been a Board Member of the RBM Partnership, has advised The Global Fund to Fight AIDS, TB & Malaria on their pricing and product quality assurance policies, and is currently a member of the Fund’s Market Dynamics Advisory Group. He is a Chartered Scientist and Chartered Chemist as well as being a Fellow of the Royal Society of Chemistry, of the Chartered Management Institute, and of the Royal Society of Tropical Medicine & Hygiene.
Professor Sir Brian Greenwood
Professor Brian Greenwood is Manson Professor of Tropical Medicine at London School of Hygiene & Tropical Medicine (LSHTM) where he coordinates the Malaria Capacity Development Consortium (MCDC), which is supporting the post graduate training of African scientists in malaria research in five African universities. He also coordinates the African Meningococcal Carriage Consortium which is investing the impact of a new vaccine against epidemic meningitis in seven countries in the African meningitis belt. Before joining the staff of LSHTM he worked for 30 years in West Africa, first in Nigeria where he helped to establish a new medical school at Ahamdu Bello University, Zaria in northern Nigeria and then for 15 years in The Gambia where he directed the Medical Research Council Laboratories. His main research interests are malaria, pneumonia and meningitis in African children.
Rt Hon Baroness Hayman GBE
Rt Hon Baroness Hayman GBE is Vice-Chairman of the All-Party Parliamentary Group on Malaria and Neglected Tropical Diseases, currently serving on the Board of Trustees of the Sabin Vaccine Institute, and is a participant of the Industry and Parliament Trust (IPT) fellowship on the pharmaceutical industry. She was previously elected as MP for Welwyn and Hatfield in October 1974, founded Maternity Alliance and joined the Royal College of Gynaecologists Ethics Committee in 1980. Following numerous roles in the health care sector, she entered the House of Lords as a Life Peer in 1996, was made a Privy Counsellor in 2001 and was Chair of Cancer Research UK and the Human Tissue Authority. From 2006 to 2011 she was elected Lord Speaker of the House of Lords, acting as an ambassador for the House at home and abroad. She has joined the Parliamentary and Political Service Honours Committee and was appointed Dame Grand Cross of the Order of the British Empre (GBE) in the New Year Honours List 2012.
Robert Seabrook QC
Robert Seabrook QC is a leading barrister in the UK, with wide ranging experience across jurisdiction. In recent years he has concentrated on clinical negligence, medical disciplinary work and substantial matrimonial finance and property cases. His forensic skills are frequently called upon for cases outside these areas such as child sex abuse, action relating to the police and medical crime.
Professor Melissa Leach
Professor Melissa Leach is a Professorial Fellow at the Institute of Development Studies (IDS) Sussex, and Director of the STEPS Centre (Social, Technological and Environmental Pathways to Sustainability). She originally trained as a geographer (MA Cambridge) and social anthropologist (PhD London). Over the last 25 years she has been closely involved both in ethnographic fieldwork, speaking four African languages, and in extensive interdisciplinary research. This has engaged anthropology with historical, ecological and science and technology studies approaches, as well as working with foresters, agricultural and medical scientists. Professor Leach's recent work has explored the politics of science and knowledge in policy processes linked to environment and health, especially vaccination, medical research trials and emerging infectious diseases.
Dr Joanna Schellenberg
Dr Joanna Schellenberg is the Reader in Epidemiology and International Health at LSHTM and is the principal investigator of IDEAS: Informed Decisions for Actions to improve Maternal and Newborn Health, a 5-year project aiming to improve the evidence base for maternal and newborn health programmes in North-Eastern Nigeria, Ethiopia and Uttar Pradesh, India. She collaborates with EQUIP, an intervention study on a quality management approach that links communities and health facilities through locally generated health data, involving Karolinska Institutet, Makerere University, Ifakara Health Institute and Evaplan. She is also the principal investigator on newborn survival in southern Tanzania through Saving Newborn Lives, the Laerdal Foundation and UNICEF. Her past positions have included co-principal investigator on an evaluation of the community effectiveness of Intermittent Preventative Treatment in Infants (IPTi) in southern Tanzania and Technical Advisor to WHO for the Multi-Country Evaluation of integrated management of childhood illness (IMCI).
Dr Nermeen Varawalla
Dr Nermeen Varawalla is currently Executive Vice President for Global Clinical Trials at Lambda Therapeutic Research, UK and is a recognised expert in Pharmaceutical Product and Medical Technology development. During her 10 years in the clinical trials industry, working at PRA International & ECCRO, she has participated in the execution of over 50 global clinical development programmes. Prior to this, Nermeen worked at Accenture’s UK Life Science & Healthcare Strategy Consulting practice. She completed her undergraduate and specialist medical training at the University of Mumbai, before receiving a Rhodes Fellowship to the University of Oxford where she obtained a DPhil from the Institute of Molecular Medicine. She is an MRCOG (Member of the Royal College of Obstetrics and Gynaecology) and holds an MBA from INSEAD.
Kate Wallace is an independent communications consultant and has some 20 years of corporate financial communications experience spanning a variety of business sectors, government organisations and charities. She has worked on a wide range of complex and high-profile assignments for major national and international organisations, both as an external consultant (e.g for Brunswick) and member of an in-house team (e.g. for the Royal Mail Share Offer). Ms Wallace's responsibilities have involved giving advice at Chairman / CEO / Board level, and planning and managing communications and media relations for organisations including Camelot, Clintons, Sport England and TPG. She has shaped and delivered executive coaching and training programmes for consultancies, including RLM Finsbury, Powerscourt and Luther Pendragon, and companies including Taylor Wimpey. Ms Wallace has also developed a passion for advising national and international charities on their communications needs and has worked in this respect with Guy's and St Thomas' Charity, World Horse Welfare and the Retired Greyhound Trust.
Roger Wilson is an international development professional who worked for the UK's Department for International Development. His experience includes governance as Chief Governance Adviser, country programme management (Malawi, Zambia and India), public service reform in the UK and developing countries, structuring project financing with a merchant bank, and commodity trading in the London commodity markets. He now works as a consultant on governance.
Rt. Revd Bishop Dinis S. Sengulane (Honorary Patron)
Dinis S. Sengulane is an Anglican Bishop of Libombos in Lichinga, Mozambique. He serves as the chair of the Mozambican Roll Back Malaria programme which has provided a great deal of support to Mozambique’s Ministry of Health and other partners. He became an Honorary Patron of Malaria Consortium in 2006.